JP2023518192A5 - - Google Patents

Info

Publication number
JP2023518192A5
JP2023518192A5 JP2022554953A JP2022554953A JP2023518192A5 JP 2023518192 A5 JP2023518192 A5 JP 2023518192A5 JP 2022554953 A JP2022554953 A JP 2022554953A JP 2022554953 A JP2022554953 A JP 2022554953A JP 2023518192 A5 JP2023518192 A5 JP 2023518192A5
Authority
JP
Japan
Prior art keywords
composition according
solution
weight
less
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022554953A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518192A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/021939 external-priority patent/WO2021183781A1/en
Publication of JP2023518192A publication Critical patent/JP2023518192A/ja
Publication of JP2023518192A5 publication Critical patent/JP2023518192A5/ja
Pending legal-status Critical Current

Links

JP2022554953A 2020-03-11 2021-03-11 合成ナノキャリアに関連する方法および組成物 Pending JP2023518192A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062988347P 2020-03-11 2020-03-11
US62/988,347 2020-03-11
PCT/US2021/021939 WO2021183781A1 (en) 2020-03-11 2021-03-11 Methods and compositions related to synthetic nanocarriers

Publications (2)

Publication Number Publication Date
JP2023518192A JP2023518192A (ja) 2023-04-28
JP2023518192A5 true JP2023518192A5 (enExample) 2024-03-21

Family

ID=75439463

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022554953A Pending JP2023518192A (ja) 2020-03-11 2021-03-11 合成ナノキャリアに関連する方法および組成物

Country Status (11)

Country Link
US (1) US20210308058A1 (enExample)
EP (1) EP4117631A1 (enExample)
JP (1) JP2023518192A (enExample)
KR (1) KR20220152263A (enExample)
CN (1) CN115484931A (enExample)
AU (1) AU2021236234A1 (enExample)
BR (1) BR112022018070A2 (enExample)
CA (1) CA3174988A1 (enExample)
IL (1) IL296326A (enExample)
MX (1) MX2022011248A (enExample)
WO (1) WO2021183781A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140041505A (ko) 2011-04-29 2014-04-04 셀렉타 바이오사이언시즈, 인크. 조절 b 세포 유도를 위한 관용원성 합성 나노운반체
BR112015027291A8 (pt) 2013-05-03 2019-12-24 Selecta Biosciences Inc uso de um imunossupressor que têm uma vida eficaz farmacodinâmica especificada e composição compreendendo o referido imunossupressor
WO2016037164A1 (en) 2014-09-07 2016-03-10 Selecta Biosciences, Inc. Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses
KR102753928B1 (ko) 2017-03-11 2025-01-14 셀렉타 바이오사이언시즈, 인크. 항염증제, 및 면역억제제를 포함하는 합성 나노담체를 사용한 조합 치료와 관련된 방법 및 조성물
EP3980784A1 (en) 2019-06-04 2022-04-13 Selecta Biosciences, Inc. Formulations and doses of pegylated uricase

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946929A (en) 1983-03-22 1990-08-07 Massachusetts Institute Of Technology Bioerodible articles useful as implants and prostheses having predictable degradation rates
US4638045A (en) 1985-02-19 1987-01-20 Massachusetts Institute Of Technology Non-peptide polyamino acid bioerodible polymers
US4806621A (en) 1986-01-21 1989-02-21 Massachusetts Institute Of Technology Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
US5804178A (en) 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
US5736372A (en) 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
CA1340581C (en) 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5019379A (en) 1987-07-31 1991-05-28 Massachusetts Institute Of Technology Unsaturated polyanhydrides
US5010167A (en) 1989-03-31 1991-04-23 Massachusetts Institute Of Technology Poly(amide-and imide-co-anhydride) for biological application
US5399665A (en) 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
US5512600A (en) 1993-01-15 1996-04-30 Massachusetts Institute Of Technology Preparation of bonded fiber structures for cell implantation
US5514378A (en) 1993-02-01 1996-05-07 Massachusetts Institute Of Technology Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US5565215A (en) 1993-07-23 1996-10-15 Massachusettes Institute Of Technology Biodegradable injectable particles for imaging
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5716404A (en) 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US6123727A (en) 1995-05-01 2000-09-26 Massachusetts Institute Of Technology Tissue engineered tendons and ligaments
US6095148A (en) 1995-11-03 2000-08-01 Children's Medical Center Corporation Neuronal stimulation using electrically conducting polymers
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
US5902599A (en) 1996-02-20 1999-05-11 Massachusetts Institute Of Technology Biodegradable polymer networks for use in orthopedic and dental applications
US6258823B1 (en) 1996-07-12 2001-07-10 Ariad Pharmaceuticals, Inc. Materials and method for treating or preventing pathogenic fungal infection
US7288266B2 (en) 1996-08-19 2007-10-30 United States Of America As Represented By The Secretary, Department Of Health And Human Services Liposome complexes for increased systemic delivery
US5837752A (en) 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
US6187335B1 (en) 1997-12-31 2001-02-13 Orasomal Technologies, Inc. Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
US6632922B1 (en) 1998-03-19 2003-10-14 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6506577B1 (en) 1998-03-19 2003-01-14 The Regents Of The University Of California Synthesis and crosslinking of catechol containing copolypeptides
US6686446B2 (en) 1998-03-19 2004-02-03 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
WO2000006120A1 (en) 1998-07-31 2000-02-10 Korea Institute Of Science And Technology Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier
EP1267946A4 (en) 2000-02-28 2008-07-02 Genesegues Inc SYSTEM AND METHOD FOR ENCAPSULATING NANOCAPSULES
WO2003020797A1 (en) 2001-08-30 2003-03-13 The Regents Of The University Of California Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
WO2004017943A2 (en) 2002-08-23 2004-03-04 Medigene Oncology Gmbh Non-vesicular cationic lipid formulations
US20050260260A1 (en) 2004-05-19 2005-11-24 Edward Kisak Liposome compositions for the delivery of macromolecules
CA2917512C (en) 2007-10-12 2025-08-05 President And Fellows Of Harvard College VACCINE NANOTECHNOLOGY
CN101676291B (zh) 2008-09-18 2012-05-09 上海海和药物研究开发有限公司 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途
KR101267813B1 (ko) * 2009-12-30 2013-06-04 주식회사 삼양바이오팜 향상된 수용해도를 갖는 라파마이신 함유 고분자나노입자 주사제형 조성물 및 그 제조방법, 및 방사선 요법과 병용하기 위한 항암 조성물
AU2012323937A1 (en) 2011-10-14 2014-06-05 Stc.Unm Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
AU2013315125B2 (en) * 2012-09-17 2018-07-26 Pfizer Inc. Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
TWI679019B (zh) * 2013-04-29 2019-12-11 法商賽諾菲公司 抗ｉｌ－４／抗ｉｌ－１３之雙特異性抗體調配物
US20150359865A1 (en) * 2014-06-17 2015-12-17 Selecta Biosciences, Inc. Tolerogenic synthetic nanocarriers for t-cell-mediated autoimmune disease
FI3834823T3 (fi) * 2014-11-05 2024-04-02 Cartesian Therapeutics Inc Menetelmiä ja koostumuksia liittyen alhaisen hlb:n omaavien pinta-aktiivisten aineiden käyttöön rapalogin käsittävien synteettisten nanokantajien valmistuksessa
WO2017031368A1 (en) * 2015-08-18 2017-02-23 Mayo Foundation For Medical Education And Research Carrier-binding agent compositions and methods of making and using the same
WO2017138983A1 (en) * 2016-02-10 2017-08-17 Pfizer Inc. Therapeutic nanoparticles having egfr ligands and methods of making and using same
GB201608323D0 (en) * 2016-05-12 2016-06-29 Ucb Biopharma Sprl Pharmaceutical compositions
US11583504B2 (en) * 2016-11-08 2023-02-21 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
WO2019162951A1 (en) * 2018-02-26 2019-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Drug delivery systems
CN112057425A (zh) * 2020-09-30 2020-12-11 严鹏科 一种雷帕霉素制剂及其制备方法

Similar Documents

Publication Publication Date Title
US10555912B2 (en) Use of polymeric excipients for lyophilization or freezing of particles
Cui et al. Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid) microspheres made by the double emulsion method
JP7218089B2 (ja) 安定した過飽和状態でラパマイシンをもつ合成ナノキャリアに関する方法および組成物
JP2022173236A5 (enExample)
ES2435944T3 (es) Nuevas formulaciones de agentes farmacológicos, métodos para su preparación y métodos para su uso
JP2017533243A5 (enExample)
JP2017537081A5 (enExample)
JP2011063596A (ja) 封入物質の制御放出のための生分解性組成物
CN101584663A (zh) 新型的注射用多西他赛脂质体给药系统及其制备方法
US20210308058A1 (en) Methods and compositions related to synthetic nanocarriers
US8734843B2 (en) Medicament sustained-release particles and method for preparing the same
Farsana et al. Hydrogel based nanosponges drug delivery for topical applications-A updated review
Mody et al. Freeze-drying of protein-loaded nanoparticles for vaccine delivery
CN103301061A (zh) 多西他赛冻干微乳制剂及其制备方法
KR100729954B1 (ko) Ｓｅｃ１ 변이 단백질의 제형 및 그것의 제형화 방법
EP4583844A1 (en) Biodegradable polymeric particles for delivery of positively charged therapeutic agents
HK40016192A (en) Use of polymeric excipients for lyophilization or freezing of particles
ES2574615A1 (es) Nanopartícula lipídica de tobramicina
Onuigboa et al. Evaluation of DOTAP liposomes as vaccine adjuvant: Formulation, in-vitro characterization and stability
HK1203366B (en) Use of polymeric excipients for lyophilization or freezing of particles